Description: WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates. The company was founded in 2013 and is headquartered in Wuxi, China. WuXi XDC Cayman Inc. operates as a subsidiary of WuXi Biologics (Cayman) Inc.
Home Page: www.youyuan.com.hk
Exchange: HK
Country: HK : Hong Kong
Currency: Hong Kong Dollar (HK$)
| GIC Sector: | Materials |
|---|---|
| GIC Group: | Materials |
| GIC Industry: | Containers & Packaging |
| GIC Sub-Industry: | Paper & Plastic Packaging Products & Materials |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 137.2727 |
| Price-to-Book MRQ: | 19.5291 |
| Price-to-Sales TTM: | 21.8607 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |